NDAORALTABLETPriority Review
Approved
Jan 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
Non-Nucleoside Reverse Transcriptase Inhibitors
Pharmacologic Class:
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Clinical Trials (5)
Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR)
Started Oct 2020
54 enrolled
HIV Infections
A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants
Started Dec 2019
32 enrolled
Healthy
Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir
Started Jan 2019
871 enrolled
HIV/AIDS
Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL
Started Jan 2015
170 enrolled
HIV-1 Infection
DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)
Started Feb 2014
42 enrolled
Infection, Human Immunodeficiency Virus